Sania Ali Yehia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sania Ali Yehia has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Amal Mohamed Dawoud
Medical Microbiology and Immunology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt
1 shared publication - Amany E. Elashkar
Clinical Pathology Department, National Liver Institute, Menoufia University, Shebin El- Kom, Egypt
1 shared publication Amira Samy Elmaghraby
Clinical Pathology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt
1 shared publicationHeba Abdelhalim
Diagnostic and Interventional Radiology Department of Diagnostic Medical Imaging and Interventional Radiology, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt
1 shared publication- Marwa Mohamed Ibrahim Khalil
Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt
1 shared publication - Salma Nagi
Pediatric Hepatology, Gastroenterology and Nutrition Department, National Liver Institute, Menoufia University, Menoufia, Egypt
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 16 (1) , 69
Assessment of IL-27 T4730C polymorphism and its serum levels in neonatal cholestasis patients
Background: The immune system and many genes have been linked to bile tract damage in neonatal cholestasis (NC), resulting in liver retention of biliary contents. The most commonly recognized cause of NC is biliary atresia (BA). Objectives: The study investigated the effect of the IL27 rs181206 polymorphism on NC risk and its potential association with blood IL-27 levels. Methodology: This study included 41 NC patients (20 BA and 21 non-BA), and 20 healthy controls. The diagnosis of NC has been confirmed by a cholestasis workup that includes radiographic evidence, laboratory-based analysis, and clinical observations. The genotype of the variation IL-27 rs181206 was assessed using a pre-made Taqman test. Serum levels of IL27 were determined using a double antibody sandwich enzyme-linked immunosorbent assay. Results: Compared to controls, individuals with NC had a greater frequency of the T allele (98.8% vs. 60%) ( P value 0.002). Those with the TT genotype had a 17.14-fold increased risk of developing NC in the dominant model [OR, 17.14 (95% CI, 1.89 to 155.14); P = 0.004]. NC infants had significantly higher serum levels of IL-27 (98.180 ± 34.96 for BA and 100.757 ± 46.42 for non-BA) than controls (76.070 ± 5.8650). However, IL-27 serum levels did not differ significantly among different genotypes. Conclusion: The T allele and TT genotype could increase the risk of NC susceptibility. Understanding IL27’s role in NC pathogenesis can help to use it as a diagnostic marker or therapeutic target.
- 22 September 2026
- Published by Springer Nature in Egyptian Liver Journal
- Vol. 16 (1) , 69
Open AccessAssessment of IL-27 T4730C polymorphism and its serum levels in neonatal cholestasis patients
Background: The immune system and many genes have been linked to bile tract damage in neonatal cholestasis (NC), resulting in liver retention of biliary contents. The most commonly recognized cause of NC is biliary atresia (BA). Objectives: The study investigated the effect of the IL27 rs181206 polymorphism on NC risk and its potential association with blood IL-27 levels. Methodology: This study included 41 NC patients (20 BA and 21 non-BA), and 20 healthy controls. The diagnosis of NC has been confirmed by a cholestasis workup that includes radiographic evidence, laboratory-based analysis, and clinical observations. The genotype of the variation IL-27 rs181206 was assessed using a pre-made Taqman test. Serum levels of IL27 were determined using a double antibody sandwich enzyme-linked immunosorbent assay. Results: Compared to controls, individuals with NC had a greater frequency of the T allele (98.8% vs. 60%) ( P value 0.002). Those with the TT genotype had a 17.14-fold increased risk of developing NC in the dominant model [OR, 17.14 (95% CI, 1.89 to 155.14); P = 0.004]. NC infants had significantly higher serum levels of IL-27 (98.180 ± 34.96 for BA and 100.757 ± 46.42 for non-BA) than controls (76.070 ± 5.8650). However, IL-27 serum levels did not differ significantly among different genotypes. Conclusion: The T allele and TT genotype could increase the risk of NC susceptibility. Understanding IL27’s role in NC pathogenesis can help to use it as a diagnostic marker or therapeutic target.